Abstract
Vitiligo is perceived as an autoimmune skin disease. Previous studies showed conflicting data about vitiligo and pregnancy outcomes. To delineate the associations between vitiligo and the pregnancy outcomes, we used the National Health Insurance Research Database of Taiwan to conduct a retrospective cohort study from January 1, 2000 to December 31, 2015. This study population was composed of 1,096 women with vitiligo and 4,384 women without vitiligo, who were all matched according to age, comorbidity, and index year. Compared with the non-vitiligo controls, women with vitiligo had a higher risk of abortion (aHR 1.158, 95% confidence interval (CI) 1.095-1.258, P < .001). Our study indicates that there is a higher risk of abortion in pregnant women with vitiligo and the control of disease activity with systemic treatment before conception could improve pregnancy outcomes.
Cite
CITATION STYLE
Hung, C. T., Huang, H. H., Wang, C. K., Chung, C. H., Tsao, C. H., Chien, W. C., & Wang, W. M. (2021). Pregnancy outcomes in women with vitiligo: A Taiwanese nationwide cohort study. PLoS ONE, 16(3 March). https://doi.org/10.1371/journal.pone.0248651
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.